IBDEI3GS ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,58270,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,58270,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,58271,0)
 ;;=E10.36^^272^2905^1
 ;;^UTILITY(U,$J,358.3,58271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58271,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,58271,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,58271,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,58272,0)
 ;;=E10.39^^272^2905^2
 ;;^UTILITY(U,$J,358.3,58272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58272,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,58272,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,58272,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,58273,0)
 ;;=E10.321^^272^2905^3
 ;;^UTILITY(U,$J,358.3,58273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58273,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58273,1,4,0)
 ;;=4^E10.321
 ;;^UTILITY(U,$J,358.3,58273,2)
 ;;=^5002594
 ;;^UTILITY(U,$J,358.3,58274,0)
 ;;=E10.329^^272^2905^4
 ;;^UTILITY(U,$J,358.3,58274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58274,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58274,1,4,0)
 ;;=4^E10.329
 ;;^UTILITY(U,$J,358.3,58274,2)
 ;;=^5002595
 ;;^UTILITY(U,$J,358.3,58275,0)
 ;;=E10.331^^272^2905^5
 ;;^UTILITY(U,$J,358.3,58275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58275,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58275,1,4,0)
 ;;=4^E10.331
 ;;^UTILITY(U,$J,358.3,58275,2)
 ;;=^5002596
 ;;^UTILITY(U,$J,358.3,58276,0)
 ;;=E10.339^^272^2905^6
 ;;^UTILITY(U,$J,358.3,58276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58276,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58276,1,4,0)
 ;;=4^E10.339
 ;;^UTILITY(U,$J,358.3,58276,2)
 ;;=^5002597
 ;;^UTILITY(U,$J,358.3,58277,0)
 ;;=E10.341^^272^2905^9
 ;;^UTILITY(U,$J,358.3,58277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58277,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58277,1,4,0)
 ;;=4^E10.341
 ;;^UTILITY(U,$J,358.3,58277,2)
 ;;=^5002598
 ;;^UTILITY(U,$J,358.3,58278,0)
 ;;=E10.349^^272^2905^10
 ;;^UTILITY(U,$J,358.3,58278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58278,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58278,1,4,0)
 ;;=4^E10.349
 ;;^UTILITY(U,$J,358.3,58278,2)
 ;;=^5002599
 ;;^UTILITY(U,$J,358.3,58279,0)
 ;;=E10.351^^272^2905^7
 ;;^UTILITY(U,$J,358.3,58279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58279,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58279,1,4,0)
 ;;=4^E10.351
 ;;^UTILITY(U,$J,358.3,58279,2)
 ;;=^5002600
 ;;^UTILITY(U,$J,358.3,58280,0)
 ;;=E10.359^^272^2905^8
 ;;^UTILITY(U,$J,358.3,58280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58280,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58280,1,4,0)
 ;;=4^E10.359
 ;;^UTILITY(U,$J,358.3,58280,2)
 ;;=^5002601
 ;;^UTILITY(U,$J,358.3,58281,0)
 ;;=E08.311^^272^2905^33
 ;;^UTILITY(U,$J,358.3,58281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58281,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58281,1,4,0)
 ;;=4^E08.311
 ;;^UTILITY(U,$J,358.3,58281,2)
 ;;=^5002510
 ;;^UTILITY(U,$J,358.3,58282,0)
 ;;=E08.319^^272^2905^34
 ;;^UTILITY(U,$J,358.3,58282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58282,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Diab Retinopathy w/o Macular Edema
